MyFinsight
Home
Blog
About
Back
Income Statement
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)
source: myfinsight.com
Net loss
-$43,423,000
(-4.78%↓ Y/Y)
Interest income
$2,323,000
(18.52%↑ Y/Y)
Loss before income
taxes
-$43,423,000
(-4.78%↓ Y/Y)
Total other income,
net
$2,270,000
(60.54%↑ Y/Y)
Other expense, net
-$53,000
(90.29%↑ Y/Y)
Loss from operations
-$45,693,000
(-6.62%↓ Y/Y)
Total operating
expenses
$45,693,000
(6.62%↑ Y/Y)
Research and development
$23,768,000
(-12.67%↓ Y/Y)
Selling, general and
administrative
$21,925,000
(40.19%↑ Y/Y)
Back